Guidance

Shiga toxin-producing Escherichia coli: public health management

Guidance for public health professionals for the management of Shiga toxin-producing Escherichia coli (STEC) infection (including O157 and non-O157).

• From: UK Health Security Agency
• Published: 8 August 2018
• Last updated: 11 January 2023
  Show all updates

  1. 11 January 2023

     Corrected note 8 in 'Algorithms for the local response to cases of STEC infection'.

  2. 10 January 2023

     Added new guidance, algorithms, leaflets and letters.

  3. 9 August 2021

     Updated 'Algorithms for the local response to cases of STEC infection', including changes to actions for cases of STEC O26.

  4. 8 August 2018

     First published.

Documents

Operational guidance for Shiga toxin-producing Escherichia coli (STEC)

Ref: UKHSA publication gateway number GOV-12746

PDF, 1.06 MB, 90 pages

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Algorithms for the local response to cases of STEC infection

Ref: UKHSA publication gateway number GOV-12746

PDF, 631 KB, 18 pages

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

STEC risk assessment proforma

Ref: UKHSA publication gateway number GOV-12746

MS Word Document, 82.8 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Template non-O157 STEC PCR letter

Ref: UKHSA publication gateway number GOV-12746

MS Word Document, 83.9 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Non-O157 STEC PCR information leaflet for cases

Ref: UKHSA publication gateway number GOV-12746

MS Word Document, 369 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

STEC O157 information leaflet for cases

Ref: UKHSA publication gateway number GOV-12746

MS Word Document, 369 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Public health practitioners should use this guidance to respond to laboratory reports or clinical notifications of infection with STEC, including O157 and non-O157 serogroups.

The guidance is accompanied by:

• template letters
• algorithms for local response to cases of infection
• a risk assessment proforma
• leaflets for cases

The guidance should be used along with the national surveillance questionnaire.

Previous versions of this guidance were published by Public Health England.